References
- Cancer statistics. CA Cancer J Clin 1988; 38: 5–22
- Schoenfeld C, Rosenbaum C, Horton J, et al. A comparison of adriamycin versus vincristine and adriamycin and cyclophosphamide for advanced sarcoma. Cancer 1982; 50: 2757–2762
- Pinedo H M, Bramwell V HC, Mouridson M D, et al. High dose ifosfamide by infusion with mesna in advanced soft tissue sarcomas. Cancer Treatment Rev 1983; 10(SupplA)163–164
- Antman K, Elias A. Chemotherapy of advanced soft tissue sarcomas. Semin Surg Oncol 1988; 4: 53–58
- Stuart-Harris R, Harper P G, Kaye S B, et al. High dose ifosfamide by infusion with mesna in advanced soft tissue sarcomas. Cancer Treat Rev 1983; 10(Suppl A)163–164
- Weiss R B. Ifosfamide vs cyclophosphamide in cancer therapy. Oncology 1991; 5: 67–76
- Dirix L Y, Van Oosterom A T. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing sarcoma and osteosarcoma: A review. Semin Oncol 1990; 17(Suppl 4)50–57
- Miller A B, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
- Benjamin R S, Wiernik P H, Bachur N T. Adriamycin chemotherapy: Efficacy, safety, and pharmacological basis of intermittent single high dose schedule. Cancer 1974; 33: 19–27
- Creagan E T, Hahn R G, Ahmann D L, et al. A clinical trial with adriamycin in advanced sarcomas. Oncology 1978; 34: 90–91
- Gottlieb J A, Benjamine R S, Baker L H, et al. Role of DTIC in the chemotherapy of sarcomas. Cancer Treat Rep 1976; 60: 199–203
- Hoefer-Janker H, Scheef U, Gunther U, et al. Ergahrungen mit der fractionierten ifosfamide-strosstherapie bei generalisierten malignant tumoren. Med Welt 1975; 26: 972–979
- Bruhl P, Gunther U, Hoefer-Janker H, et al. Results obtained with fractionated ifosfamide massive dose treatment in generalized massive tumors. Int J Clin Pharmacol 1976; 14: 29–37
- Wiltshow E, Westbury G, Harme C, et al. Ifosfamide and Mesna with and without adriamycin in soft tissue sarcoma. Cancer Chemother Pharmacol 1983; 11: 69–72
- Antman K H, Ryan L, Elias A, et al. Response to ifosfamide and Mesna: 124 previously treated patients with metastatic or unresectable carcinoma. J Clin Oncol 1989; 1: 126–131
- Chevallier B, Leyvraz S, Oliver J P, et al. Epirubicine and ifosfamide in advanced soft tissue sarcoma A phase II study. Cancer Invest 1993; 11: 135–139